Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors

MLA

Jing Chen, et al. “Mefloquine Enhances the Efficacy of Anti-PD-1 Immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-Induced Ferroptosis in Tumors.” Journal for ImmunoTherapy of Cancer, vol. 12, no. 3, Mar. 2024. EBSCOhost, https://doi.org/10.1136/jitc-2023-008554.

APA

Jing Chen, Jie Wu, Xiang Chen, Qian Tao, Nian Liu, & Cong Peng. (2024). Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. Journal for ImmunoTherapy of Cancer, 12(3). https://doi.org/10.1136/jitc-2023-008554

Chicago

Jing Chen, Jie Wu, Xiang Chen, Qian Tao, Nian Liu, and Cong Peng. 2024. “Mefloquine Enhances the Efficacy of Anti-PD-1 Immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-Induced Ferroptosis in Tumors.” Journal for ImmunoTherapy of Cancer 12 (3). doi:10.1136/jitc-2023-008554.